Combined-modality Therapy for Locally Advanced Esophageal Cancer in Endemic Region of Turkey: A Single-Center Multimodal Experience

Creative Commons License

Basaran H., Arslan D., Ozdemir O., Turna M., Ozdemir Y., Karaca S., ...Daha Fazla

IRANIAN RED CRESCENT MEDICAL JOURNAL, cilt.23, sa.3, 2021 (SCI-Expanded)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.32592/ircmj.2021.23.3.325
  • Dergi Adı: IRANIAN RED CRESCENT MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), CAB Abstracts, EMBASE, Veterinary Science Database
  • Anahtar Kelimeler: Chemoradiotherapy, Esophageal cancer, Prognosis, Survival, PHASE-III TRIAL, RADIATION-THERAPY, RANDOMIZED-TRIAL, SURGERY, CHEMORADIOTHERAPY, ADENOCARCINOMA
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Esophageal cancer (EC) is known as the most common cancer around the world. The evidence supports that preoperative chemoradiotherapy (CRT) improves resectability and survival in locally advanced EC patients.